The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss (Q34686787)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss |
scientific article |
Statements
1 reference
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss (English)
1 reference
Andre J van Wijnen
1 reference
Gary S Stein
1 reference
Jane B Lian
1 reference
Janet L Stein
1 reference
Meghan E McGee-Lawrence
1 reference
Jitesh Pratap
1 reference
Jennifer J Westendorf
1 reference
Sadiq Hussain
1 reference
Jacqueline Akech
1 reference
John J Wixted
1 reference
Gabriela Szabo
1 reference
Xiaodong Li
1 reference
Krystin Bedard
1 reference
Robinder J Dhillon
1 reference
1 December 2010
1 reference
1 reference
9
1 reference
12
1 reference
3210-3220
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference